Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 158

1.

The role of natriuretic peptides as biomarkers for guiding the management of chronic heart failure.

Motiwala SR, Januzzi JL Jr.

Clin Pharmacol Ther. 2013 Jan;93(1):57-67. doi: 10.1038/clpt.2012.187. Epub 2012 Nov 28. Review.

PMID:
23187878
2.

The role of natriuretic peptide testing in guiding chronic heart failure management: review of available data and recommendations for use.

Januzzi JL Jr.

Arch Cardiovasc Dis. 2012 Jan;105(1):40-50. doi: 10.1016/j.acvd.2011.10.007. Epub 2012 Jan 16. Review.

3.

Are serial BNP measurements useful in heart failure management? Serial natriuretic peptide measurements are useful in heart failure management.

Januzzi JL, Troughton R.

Circulation. 2013 Jan 29;127(4):500-7; discussion 508. doi: 10.1161/CIRCULATIONAHA.112.120485. Review.

4.

Natriuretic Peptides and the Management of Heart Failure.

Kern T, Kedan I, Kimchi A.

Rev Cardiovasc Med. 2015;16(2):95-104. Review.

PMID:
26198556
5.

Natriuretic peptides in the diagnosis and management of acute heart failure.

Mohammed AA, Januzzi JL Jr.

Heart Fail Clin. 2009 Oct;5(4):489-500. doi: 10.1016/j.hfc.2009.04.007.

PMID:
19631174
6.

Natriuretic Peptide-guided therapy for heart failure.

Mentz RJ, Felker GM.

Circ J. 2011;75(9):2031-7. Epub 2011 Jul 27. Review.

7.

Using biomarkers to "guide" heart failure management: current perspectives and future directions.

Motiwala SR, Januzzi JL Jr.

Cardiol Rev. 2013 May-Jun;21(3):127-34. doi: 10.1097/CRD.0b013e3182769073. Review.

PMID:
23032578
8.

[Natriuretic peptides--new diagnostic markers in heart disease].

Angermann CE, Ertl G.

Herz. 2004 Sep;29(6):609-17. Review. German.

PMID:
15912436
9.

Therapeutic implications of biomarkers in chronic heart failure.

Ahmad T, O'Connor CM.

Clin Pharmacol Ther. 2013 Oct;94(4):468-79. doi: 10.1038/clpt.2013.139. Epub 2013 Jul 15. Review.

PMID:
23856627
10.

Biomarker-guided therapy in chronic heart failure: a meta-analysis of randomized controlled trials.

Felker GM, Hasselblad V, Hernandez AF, O'Connor CM.

Am Heart J. 2009 Sep;158(3):422-30. doi: 10.1016/j.ahj.2009.06.018. Epub 2009 Jul 9.

PMID:
19699866
11.

Natriuretic peptide testing for heart failure therapy guidance in the inpatient and outpatient setting.

Green SM, Green JA, Januzzi JL Jr.

Am J Ther. 2009 Mar-Apr;16(2):171-7. doi: 10.1097/MJT.0b013e318172797f. Review.

PMID:
19300043
12.

Natriuretic peptides in the diagnosis and management of chronic heart failure.

Boerrigter G, Costello-Boerrigter LC, Burnett JC Jr.

Heart Fail Clin. 2009 Oct;5(4):501-14. doi: 10.1016/j.hfc.2009.04.002. Review.

13.

Old and new biomarkers of heart failure.

Emdin M, Vittorini S, Passino C, Clerico A.

Eur J Heart Fail. 2009 Apr;11(4):331-5. doi: 10.1093/eurjhf/hfp035. Review.

14.

Drug and device effects on peak oxygen consumption, 6-minute walk distance, and natriuretic peptides as predictors of therapeutic effects on mortality in patients with heart failure and reduced ejection fraction.

Wessler BS, Kramer DG, Kelly JL, Trikalinos TA, Kent DM, Konstam MA, Udelson JE.

Circ Heart Fail. 2011 Sep;4(5):578-88. doi: 10.1161/CIRCHEARTFAILURE.111.961573. Epub 2011 Jun 24. Review.

15.

Natriuretic peptides as a prognostic marker and therapeutic target in heart failure.

Wright GA, Struthers AD.

Heart. 2006 Feb;92(2):149-51. Epub 2005 Oct 10.

16.

B-type natriuretic peptide-guided heart failure therapy: A meta-analysis.

Porapakkham P, Porapakkham P, Zimmet H, Billah B, Krum H.

Arch Intern Med. 2010 Mar 22;170(6):507-14. doi: 10.1001/archinternmed.2010.35.

PMID:
20308637
17.

Clinical findings, natriuretic peptides, and echocardiography: integrating tools to optimize heart failure management.

Beck-da-Silva L, Rohde LE, Goldraich L, Clausell N.

Congest Heart Fail. 2007 May-Jun;13(3):158-63. Review.

18.

The potential role of natriuretic peptide-guided management for patients hospitalized for heart failure.

Maisel A, Xue Y, Greene SJ, Pang PS, Januzzi JL, PiƱa IL, DeFilippi C, Butler J.

J Card Fail. 2015 Mar;21(3):233-9. doi: 10.1016/j.cardfail.2014.11.009. Epub 2014 Nov 26. Review.

PMID:
25433362
19.

Troponin elevation in heart failure prevalence, mechanisms, and clinical implications.

Kociol RD, Pang PS, Gheorghiade M, Fonarow GC, O'Connor CM, Felker GM.

J Am Coll Cardiol. 2010 Sep 28;56(14):1071-8. doi: 10.1016/j.jacc.2010.06.016. Review.

20.

Outpatient monitoring and treatment of chronic heart failure guided by amino-terminal pro-B-type natriuretic peptide measurement.

Troughton RW, Richards AM.

Am J Cardiol. 2008 Feb 4;101(3A):72-5. doi: 10.1016/j.amjcard.2007.11.027. Review.

PMID:
18243863

Supplemental Content

Support Center